ALBUQUERQUE, NM – NOVEMBER 13, 2014 UNM melanoma technology developed by Dr. Yubin Miao from the Department of Pharmaceutical Sciences at the College of Pharmacy was recently named as one of the “Top 10 Interesting Oncology Projects to Watch for 2014,” by consulting and market research firms Informa and Kantar Health. The technology is being commercialized by local start-up SolaranRx. To read more, see Dan Mayfield’s Nov. 12 article, “National Award Could Bolster SolaranxRx Capital Raise,” from Albuquerque Business First, at http://www.bizjournals.com/albuquerque/news/2014/11/12/national-award-could-bolster-solaranrx-capital.html.
Also see a related profile of SolaranRx in Startup Magazine at http://www.thebiosciencecenter.com/uncategorized/solaranrx-profiled-startup-magazine and a press release at https://stc.unm.edu/news/news.php?newsid=595.
FOR MORE INFORMATION, CONTACT: